Related Experiment Video
Updated: Jul 15, 2026

Freezing Injury in Mouse Masseter Muscle to Establish an Orofacial Muscle Fibrosis Model
Published on: December 29, 2023
Fibroblast growth factor (FGF)23 in patients with acromegaly
Nobuaki Ito1, Seiji Fukumoto, Manabu Taguchi
1Division of Nephrology & Endocrinology, Department of Medicine, The University of Tokyo Hospital, Japan.
Abstract:
Fibroblast growth factor (FGF)23 is a hormone that regulates serum phosphate and 1,25-dihydroxyvitamin D levels. Hyperphosphatemia is sometimes observed in patients with acromegaly while the detailed mechanism of this abnormal phosphate metabolism remains to be elucidated. We have measured FGF23 levels in 18 patients before and after the surgery for acromegaly. Serum GH, IGF-I and phosphate significantly decreased after the surgery. In addition, FGF23 also reduced by the surgery. These results indicate that deficient action of FGF23 is not the cause of deranged phosphate metabolism in patients with acromegaly.
Related Concept Videos
Introduction to Fibroblasts
TGF - β Signaling Pathway
